From: Role of stem cells in cancer therapy and cancer stem cells: a review
Authors | Type of cancer | No. of pats | RCT/CT | Conclusion |
---|---|---|---|---|
Storek et al [42] | Haematological malignancies | 140 | RCT | PBSC yields higher lymphocyte subset counts and is associated with fewer infections |
Hernandez et al [43] | Haematological malignancies | 12 | RCT | No significant difference in T, B and NK lymphoid cells reconstitution but PBSC influence faster reconstitution of cytotoxic subsets (CD8+/HLADR+ and NK lymphoid cells) |
Talmadge et al [18] | Intermediate and high grade non-Hodgkin's lymphoma | 116 | RCT | The CD4:CD8 and CD45RA:CD45RO ratios were higher in the PBSC group. Accelerated reconstitution of NK cell activity following PBSC compared to BM. |
Oehler et al [115] | Chronic myeloid leukaemia | 72 | CT | No statistically significant difference in acute or chronic GVHD, OS and disease free survival. |
Heldal et al [116] | Haematological malignancies | 61 | CT | Statistically significant enhanced graft versus leukemia effect in allo PBSC group |
Couban et al [41] | Haematological malignancies | 228 | RCT | Faster haematological recovery and improved survival in PBSC but no difference in GVHD |
Nucci et al [117] | Haematological malignancies | 56 | RCT | Shorter duration of neutropenia in PBSC group but higher incidence of extensive chronic GVHD |
Powles et al [118] | Haematological malignancies | 39 | RCT | Faster haematopoietic and immune recovery in PBSC and no difference in GVHDand OS |
Mahmoud et al [119] | Haematological malignancies | 30 | RCT | Faster haematopoietic reconstitution in PBSC group with no difference in GVHD |